Advanced Medical Optics' Visx buy delayed:
This article was originally published in Clinica
Executive Summary
Advanced Medical Optics says its acquisition of Santa Clara, California-based laser vision correction firm Visx will be delayed by the audit of their financial results. AMO had hoped to close the $1.3bn deal, which was signed in November 2004, in the first quarter of 2005. The Santa Ana, California acquirer said the audited year-end financial statements for both companies must now be included in the proxy statement and prospectus before shareholders vote on the transaction. The acquisition is now expected to close during the second quarter.
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.